Format

Send to

Choose Destination
JAMA. 2018 Jun 12;319(22):2271-2272. doi: 10.1001/jama.2018.3478.

Antitrust, Market Exclusivity, and Transparency in the Pharmaceutical Industry.

Author information

1
Program On Regulation Therapeutics, And Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
2
Center for Health Policy and Law, Northeastern University School of Law, Boston, Massachusetts.
3
Rutgers Law School, Rutgers University, Camden, New Jersey.
PMID:
29801104
DOI:
10.1001/jama.2018.3478
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center